9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association ConsortiumWARREN, Helen; DUDBRIDGE, Frank; BROEKS, Annegien et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 10, pp 1783-1791, issn 1055-9965, 9 p.Article

Genetic variants within miR-126 and miR-335 are not associated with breast cancer riskRONGXI YANG; DICK, Michelle; SCHOTT, Sarah et al.Breast cancer research and treatment. 2011, Vol 127, Num 2, pp 549-554, issn 0167-6806, 6 p.Article

Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 ControlsFLETCHER, Olivia; JOHNSON, Nichola; BARTRAM, Claus R et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 9, pp 2143-2151, issn 1055-9965, 9 p.Article

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trialTUTT, Andrew; ROBSON, Mark; WARDLEY, Andrew et al.Lancet (British edition). 2010, Vol 376, Num 9737, pp 235-244, issn 0140-6736, 10 p.Article

Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancerWIRTENBERGER, Michael; TCHATCHOU, Sandrine; WEBER, Bernhard H. F et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 11, pp 2201-2208, issn 0143-3334, 8 p.Article

19p13.1 Is a Triple-Negative―Specific Breast Cancer Susceptibility LocusSTEVENS, Kristen N; FREDERICKSEN, Zachary; CHANG-CLAUDE, Jenny et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 7, pp 1795-1803, issn 0008-5472, 9 p.Article

A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer riskRONGXI YANG; SCHLEHE, Bettina; ARNOLD, Norbert et al.Breast cancer research and treatment. 2010, Vol 121, Num 3, pp 693-702, issn 0167-6806, 10 p.Article

No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort studyREBBECK, Timothy R; ANTONIOU, Antonis C; GREENE, Mark H et al.Breast cancer research and treatment. 2009, Vol 115, Num 1, pp 185-192, issn 0167-6806, 8 p.Article

Association of a Common AKAP9 Variant With Breast Cancer Risk : A Collaborative AnalysisFRANK, Bernd; WIESTLER, Miriam; MEINDL, Alfons et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 6, pp 437-442, issn 0027-8874, 6 p.Article

SNPs in ultraconserved elements and familial breast cancer riskRONGXI YANG; FRANK, Bernd; WEBER, Bernhard H. F et al.Carcinogenesis (New York. Print). 2008, Vol 29, Num 2, pp 351-355, issn 0143-3334, 5 p.Article

Limited relevance of the CHEK2 gene in hereditary breast cancerDUFAULT, Michael R; BETZ, Beate; VON LINDERN, Celia et al.International journal of cancer. 2004, Vol 110, Num 3, pp 320-325, issn 0020-7136, 6 p.Article

Expression of the tumor suppressor gene PTEN is not altered in the progression of ovarian carcinomas and does not correlate with p27^Kip1 expressionSCHÖNDORF, Thomas; HOOPMANN, Markus; EVERSHEIM, Barbara et al.Oncology reports. 2003, Vol 10, Num 6, pp 1717-1722, issn 1021-335X, 6 p.Article

The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriersLAITMAN, Yael; KUCHENBAECKER, Karoline B; SCHMUTZLER, Rita K et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 1119-1126, issn 0167-6806, 8 p.Article

A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer riskFURU WANG; ZHIBIN HU; MEINDL, Alfons et al.Breast cancer research and treatment. 2011, Vol 127, Num 3, pp 769-775, issn 0167-6806, 7 p.Article

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trialAUDEH, M. William; CARMICHAEL, James; LU, n et al.Lancet (British edition). 2010, Vol 376, Num 9737, pp 245-251, issn 0140-6736, 7 p.Article

Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersANTONIOU, Antonis C; SPURDLE, Amanda B; HOFMANN, Wera et al.American journal of human genetics. 2008, Vol 82, Num 4, pp 937-948, issn 0002-9297, 12 p.Article

Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancerVERSMOLD, Beatrix; FELSBERG, Jörg; PIETSCH, Torsten et al.International journal of cancer. 2007, Vol 121, Num 3, pp 547-554, issn 0020-7136, 8 p.Article

The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancerWIRTENBERGER, Michael; SCHMUTZHARD, Julia; NIEDERACHER, Dieter et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 2, pp 423-426, issn 0143-3334, 4 p.Article

Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer riskVACLAVICEK, Annika; LORENZO BERMEJO, Justo; HEMMINKI, Kari et al.Breast cancer research and treatment. 2007, Vol 106, Num 2, pp 205-213, issn 0167-6806, 9 p.Article

Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancerWIRTENBERGER, Michael; FRANK, Bernd; NIEDERACHER, Dieter et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 8, pp 1655-1660, issn 0143-3334, 6 p.Article

A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any AgeAHSAN, Habibul; HALPERN, Jerry; ROY, Shantanu et al.Cancer epidemiology, biomarkers & prevention. 2014, Vol 23, Num 4, pp 658-669, issn 1055-9965, 12 p.Article

A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivityBECKER, Alexandra A; GRAESER, Monika K; LANDWEHR, Christina et al.Breast cancer research and treatment. 2012, Vol 135, Num 1, pp 167-175, issn 0167-6806, 9 p.Article

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)MAVADDAT, Nasim; BARROWDALE, Daniel; MULLIGAN, Anna Marie et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 1, pp 134-147, issn 1055-9965, 14 p.Article

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneMEINDL, Alfons; HELLEBRAND, Heide; RAMSER, Juliane et al.Nature genetics. 2010, Vol 42, Num 5, pp 410-414, issn 1061-4036, 5 p.Article

A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal womenTCHATCHOU, Sandrine; JUNG, Anke; DITSCH, Nina et al.Carcinogenesis (New York. Print). 2009, Vol 30, Num 1, pp 59-64, issn 0143-3334, 6 p.Article